The Joint Corp. (JYNT) Now Covered by Craig Hallum
Analysts at Craig Hallum started coverage on shares of The Joint Corp. (NASDAQ:JYNT) in a research note issued to investors on Wednesday, The Fly reports. The firm set a “buy” rating on the stock.
Several other equities research analysts also recently weighed in on JYNT. Zacks Investment Research downgraded The Joint Corp. from a “hold” rating to a “sell” rating in a report on Tuesday, April 4th. Maxim Group reiterated a “buy” rating and issued a $7.00 price target (up from $5.00) on shares of The Joint Corp. in a report on Friday, March 10th. Feltl & Co. reiterated a “buy” rating on shares of The Joint Corp. in a report on Friday, March 10th. Finally, ValuEngine upgraded The Joint Corp. from a “sell” rating to a “hold” rating in a report on Tuesday, June 6th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and three have assigned a buy rating to the stock. The Joint Corp. has a consensus rating of “Hold” and an average target price of $5.50.
The Joint Corp. (NASDAQ JYNT) opened at 3.7657 on Wednesday. The firm has a 50-day moving average price of $3.90 and a 200-day moving average price of $3.55. The stock’s market capitalization is $49.26 million. The Joint Corp. has a 52 week low of $1.85 and a 52 week high of $4.74.
WARNING: This story was posted by American Banking News and is the sole property of of American Banking News. If you are viewing this story on another domain, it was stolen and reposted in violation of United States and international trademark and copyright laws. The original version of this story can be accessed at https://www.americanbankingnews.com/2017/06/14/the-joint-corp-jynt-now-covered-by-craig-hallum.html.
In other The Joint Corp. news, Director James H. Amos, Jr. purchased 10,000 shares of The Joint Corp. stock in a transaction dated Wednesday, March 29th. The shares were purchased at an average cost of $3.98 per share, for a total transaction of $39,800.00. Following the completion of the acquisition, the director now owns 29,345 shares in the company, valued at approximately $116,793.10. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, major shareholder Glenhill Advisors Llc sold 86,428 shares of the stock in a transaction that occurred on Tuesday, March 28th. The stock was sold at an average price of $3.40, for a total value of $293,855.20. The disclosure for this sale can be found here. Corporate insiders own 14.60% of the company’s stock.
Large investors have recently modified their holdings of the company. Pekin Singer Strauss Asset Management IL increased its position in The Joint Corp. by 49.5% in the fourth quarter. Pekin Singer Strauss Asset Management IL now owns 55,377 shares of the company’s stock valued at $147,000 after buying an additional 18,340 shares during the last quarter. Russell Investments Group Ltd. purchased a new position in The Joint Corp. during the fourth quarter valued at approximately $171,000. Vanguard Group Inc. increased its position in The Joint Corp. by 1.1% in the first quarter. Vanguard Group Inc. now owns 76,175 shares of the company’s stock valued at $320,000 after buying an additional 800 shares during the last quarter. Skylands Capital LLC increased its position in The Joint Corp. by 4.1% in the first quarter. Skylands Capital LLC now owns 565,229 shares of the company’s stock valued at $2,374,000 after buying an additional 22,500 shares during the last quarter. Finally, Sanders Morris Harris Inc. increased its position in The Joint Corp. by 0.3% in the first quarter. Sanders Morris Harris Inc. now owns 2,607,807 shares of the company’s stock valued at $10,952,000 after buying an additional 7,200 shares during the last quarter. Hedge funds and other institutional investors own 45.71% of the company’s stock.
The Joint Corp. Company Profile
The Joint Corp. develops, owns, operates, supports and manages chiropractic clinics through direct ownership, management arrangements, franchising and the sale of regional developer rights throughout the United States. The Company is franchisor and operator of chiropractic clinics. The Company offers its patients the opportunity to visit its clinics without an appointment and receive prompt attention.
Receive News & Ratings for The Joint Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Joint Corp. and related companies with MarketBeat.com's FREE daily email newsletter.